Market Cap (In AUD)
3.7 Million
Revenue (In AUD)
8.67 Million
Net Income (In AUD)
-5.06 Million
Avg. Volume
146.22 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.039-0.27
- PE
- -0.55
- EPS
- -0.12
- Beta Value
- 1.734
- ISIN
- AU000000VTI2
- CUSIP
- -
- CIK
- -
- Shares
- 56131400.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Juan Carlos Aragon
- Employee Count
- -
- Website
- https://www.vtivision.com
- Ipo Date
- 2017-03-27
- Details
- Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. The company's flagship product comprises NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. Visioneering Technologies, Inc. was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
More Stocks
-
2428
-
IS7
-
SF3STS Group AG
SF3
-
YSN
-
IXX
-
NGCG
-
COMCatenon, S.A.
COM
-
5225